Shay Shemesh
Fortune : 17 M $ au 31/05/2026
Fortune : 17 M $ au 31/05/2026
Shay Shemesh is the founder of Nuvectis Pharma, Inc., founded in 2020, holding the title Chief Development & Operations Officer, EVP.
Former jobs include Head-Clinical Operations at Keryx Biopharmaceuticals, Inc. and Senior VP-Clinical & Regulatory Affairs at Stemline Therapeutics, Inc. from 2015 to 2020.
Education includes undergraduate and graduate degrees from Bar-Ilan University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUVECTIS PHARMA, INC. 6,76 % | 13/04/2026 | 1 793 068 ( 6,76 % ) | 17 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NUVECTIS PHARMA, INC. | Fondateur | 27/07/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
| KERYX BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
Stemline Therapeutics, Inc.
Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops medicines for treatment of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national